EMERYVILLE, Calif., July 11, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY) provided a synopsis of its accomplishments and progress during the first part of 2011, the company's outlook for the remainder of 2011, as well as report on the expected use of current cash, including approximately $7.7 million it will receive from multiple sources.
